25 related articles for article (PubMed ID: 28765903)
1. NEAT1 repression by MED12 creates chemosensitivity in p53 wild-type breast cancer cells.
Zhang S; Kim EJ; Huang J; Liu P; Donahue K; Wang Q; Wang Y; Mcilwain S; Xie L; Chen X; Li L; Xu W
FEBS J; 2024 May; 291(9):1909-1924. PubMed ID: 38380720
[TBL] [Abstract][Full Text] [Related]
2. Nicotine induces aberrant hypermethylation of tumor suppressor genes in pancreatic epithelial ductal cells.
Jin T; Hao J; Fan D
Biochem Biophys Res Commun; 2018 May; 499(4):934-940. PubMed ID: 29626481
[TBL] [Abstract][Full Text] [Related]
3. lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR‑26b to activate CTGF/ANGPT2.
Zheng J; Hu L; Cheng J; Xu J; Zhong Z; Yang Y; Yuan Z
Int J Mol Med; 2018 Jul; 42(1):489-496. PubMed ID: 29620147
[TBL] [Abstract][Full Text] [Related]
4. Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity.
Turrell FK; Kerr EM; Gao M; Thorpe H; Doherty GJ; Cridge J; Shorthouse D; Speed A; Samarajiwa S; Hall BA; Griffiths M; Martins CP
Genes Dev; 2017 Jul; 31(13):1339-1353. PubMed ID: 28790158
[TBL] [Abstract][Full Text] [Related]
5. Δ133p53 coordinates ECM-driven morphogenesis and gene expression in three-dimensional mammary epithelial acini.
Lee SY; Robertson C; Diot A; Meuray V; Bourdon JC; Bissell MJ
J Cell Sci; 2022 Nov; 135(21):. PubMed ID: 36239052
[TBL] [Abstract][Full Text] [Related]
6. Linking Oxidative Stress and DNA Damage to Changes in the Expression of Extracellular Matrix Components.
Martins SG; Zilhão R; Thorsteinsdóttir S; Carlos AR
Front Genet; 2021; 12():673002. PubMed ID: 34394183
[TBL] [Abstract][Full Text] [Related]
7. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway.
Li Q; Ma Y; Liu XL; Mu L; He BC; Wu K; Sun WJ
Oncol Rep; 2020 Nov; 44(5):2093-2107. PubMed ID: 32901874
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of fibronectin following loss of p53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype.
Yokoi A; Matsumoto T; Oguri Y; Hasegawa Y; Tochimoto M; Nakagawa M; Saegusa M
Cell Commun Signal; 2020 Jul; 18(1):103. PubMed ID: 32635925
[TBL] [Abstract][Full Text] [Related]
9. [Expression of NUF2 in breast cancer and its clinical significance].
Sun J; Chen J; Wang Z; Deng Y; Liu L; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):591-597. PubMed ID: 31140425
[TBL] [Abstract][Full Text] [Related]
10. Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.
Oh SJ; Jung SP; Han J; Kim S; Kim JS; Nam SJ; Lee JE; Kim JH
Oncol Rep; 2013 Apr; 29(4):1343-8. PubMed ID: 23353996
[TBL] [Abstract][Full Text] [Related]
11. p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
[TBL] [Abstract][Full Text] [Related]
12. Wild-type p53 controls the level of fibronectin expression in breast cancer cells.
You D; Jung SP; Jeong Y; Bae SY; Kim S
Oncol Rep; 2017 Oct; 38(4):2551-2557. PubMed ID: 28765903
[TBL] [Abstract][Full Text] [Related]
13. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
Han J; Kim S; Yang JH; Nam SJ; Lee JE
Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
[TBL] [Abstract][Full Text] [Related]
14. Berberine suppresses TPA-induced fibronectin expression through the inhibition of VEGF secretion in breast cancer cells.
Kim S; Oh SJ; Lee J; Han J; Jeon M; Jung T; Lee SK; Bae SY; Kim J; Gil WH; Kim SW; Lee JE; Nam SJ
Cell Physiol Biochem; 2013; 32(5):1541-50. PubMed ID: 24335179
[TBL] [Abstract][Full Text] [Related]
15. Effect of berberine on p53 expression by TPA in breast cancer cells.
Kim S; Han J; Kim NY; Lee SK; Cho DH; Choi MY; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE
Oncol Rep; 2012 Jan; 27(1):210-5. PubMed ID: 21964832
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
